Workflow
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
BaxterBaxter(US:BAX) Globenewswireยท2025-10-19 00:17

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Baxter International Inc. common stock between February 23, 2022, and July 30, 2025, due to alleged misleading information regarding the safety and efficacy of the Novum LVP product line [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Baxter failed to disclose systemic defects in the Novum LVP, which led to malfunctions that posed serious risks to patients, including underinfusion, overinfusion, and non-delivery of fluids [5]. - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths related to these defects but did not take adequate remedial measures [5]. - The lawsuit alleges that Baxter's statements regarding the safety, efficacy, product rollout, customer feedback, and sales prospects of the Novum LVPs were materially false and misleading [5]. Group 2: Class Action Participation - Investors who purchased Baxter common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6].